Krasnowska M, Liebhart E, Małolepszy J
Katedry i Kliniki Chorób Wewnetrznych i Alergologii AM, Wrocławiu.
Pneumonol Alergol Pol. 1994;62(7-8):365-9.
Salbutamol alone (400 micrograms per day) or salbutamol together with beclocort (1 mg per day) was used in 20 patients with mild asthma. 12 patients received during a month salbutamol combined with nedocromil (Tilade 8 mg per day). Prior starting treatment and after concluding a histamine provocation challenge was performed allowing to assess the bronchodilating properties of salbutamol. We conclude that: salbutamol alone produced a statistically nonsignificant increase of bronchial hyperactivity; a combination of salbutamol with beclocort or nedocromil did not increase the bronchial hyperactivity; during the three month trial with salbutamol alone or in a combination with a antiinflammatory agent the bronchodilatatory effect of salbutamol remained the same.
20例轻度哮喘患者使用了单独的沙丁胺醇(每日400微克)或沙丁胺醇联合倍氯米松(每日1毫克)。12例患者在一个月内接受了沙丁胺醇联合奈多罗米(替乐定,每日8毫克)治疗。在开始治疗前和结束后进行了组胺激发试验,以评估沙丁胺醇的支气管扩张特性。我们得出结论:单独使用沙丁胺醇使支气管高反应性有统计学意义但不显著的增加;沙丁胺醇与倍氯米松或奈多罗米联合使用并未增加支气管高反应性;在单独使用沙丁胺醇或与抗炎药联合使用的三个月试验期间,沙丁胺醇的支气管扩张作用保持不变。